EYES - IPO today
Summary
•Medical device company that develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients.
•Implanted about 90 units of current product.
•Laying foundation for major sales growth.
•Sept. 9 mos rev +88%. Gross margin improved to -14% from -306%. Operating loss is -851% of rev. |
发表于 2014-11-19 13:12
| 
